A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

BACKGROUND: Papulopustular rash is a common class effect of epidermal growth factor receptor inhibitors (EGFRI) that can affect patients’ health-related quality of life and cause disruptions to treatment. SWOG S1013 (NCT01416688) is a multi-center study designed to validate the Functional Assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Siu-Fun, Unger, Joseph M., Wade, James L., Wagner, Lynne I., Lacouture, Mario E., Humphries, Keisha C., Moseley, Anna, Arnold, Kathryn, Velasco, Mario R., Floyd, Justin D., Esparaz, Benjamin T., Barzi, Afsaneh, Lenz, Heinz-Josef, Koczywas, Marianna, Dakhil, Shaker, Burton, Gary V., Fisch, Michael J., Henry, N. Lynn, Hershman, Dawn L., Moinpour, Carol M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343679/
https://www.ncbi.nlm.nih.gov/pubmed/32642992
http://dx.doi.org/10.1186/s41687-020-00220-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343679/
https://www.ncbi.nlm.nih.gov/pubmed/32642992
http://dx.doi.org/10.1186/s41687-020-00220-x

Ejemplares similares